Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease

• Egile Nagusiak: Timo Friedrich (Egilea), Aaron M. Lambert (Egilea), Mark A. Masino (Egilea), Gerald B. Downes (Egilea)
• Formatua: Liburua
• Argitaratua: The Company of Biologists, 2012-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

SUMMARY Analysis of zebrafish mutants that demonstrate abnormal locomotive behavior can elucidate the molecular requirements for neural network function and provide new models of human disease. Here, we show that zebrafish quetschkommode (que) mutant larvae exhibit a progressive locomotor defect tha...